Évolution moléculaire dirigée (MeSH) < Évérolimus (MeSH) < Évérolimus (administration et posologie)

Facettes : Author.f AffPays.f AffRegion.f AffVille.f AffOrg.f Mesh.f MeshFr.f KwdFr.f

List of bibliographic references indexed by Évérolimus (MeSH)

Number of relevant bibliographic references: 26.
[0-20] [0 - 20][0 - 26][20-25][20-40]

Ident.	Authors (with country if any)	Title
000B65 (2015)	N. Polanco [Espagne] ; E. González Monte [Espagne] ; M D Folgueira [Espagne] ; E. Morales [Espagne] ; E. Gutiérrez Martínez [Espagne] ; I. Bengoa [Espagne] ; A. Hernández [Espagne] ; J M Morales [Espagne] ; M. Praga [Espagne] ; A. Andrés [Espagne]	Everolimus-based immunosuppression therapy for BK virus nephropathy.
000C02 (2015)	Christoph Aderhold [Allemagne] ; Anne Faber [Allemagne] ; Claudia Umbreit [Allemagne] ; Richard Birk [Allemagne] ; Christel Weiss [Allemagne] ; Jörg Ulrich Sommer [Allemagne] ; Karl Hörmann [Allemagne] ; Johannes David Schultz [Allemagne]	Targeting mTOR and AREG with everolimus, sunitinib and sorafenib in HPV-positive and -negative SCC.
000C42 (2015)	Marie-Charlotte Loron [Oman] ; Steven Grange [France] ; Dominique Guerrot [France] ; Frédéric Di Fiore [France] ; Caroline Freguin [France] ; Mélanie Hanoy [France] ; Frank Le Roy [France] ; Gwenaelle Poussard [France] ; Isabelle Etienne [France] ; Bruno Legallicier [France] ; Christian Pfister [France] ; Michel Godin [France] ; Dominique Bertrand [France]	Pneumocystis jirovecii pneumonia in everolimus-treated renal cell carcinoma.
000D01 (2015)	Massimo Rittà [Italie] ; Cristina Costa [Italie] ; Paolo Solidoro [Italie] ; Francesca Sidoti [Italie] ; Daniela Libertucci [Italie] ; Massimo Boffini [Italie] ; Mauro Rinaldi [Italie] ; Sergio Baldi [Italie] ; Rossana Cavallo [Italie]	Everolimus-based immunosuppressive regimens in lung transplant recipients: impact on CMV infection.
000D59 (2015)	Konrad Klinghammer [Allemagne] ; Jan-Dirk Raguse ; Thomas Plath ; Andreas E. Albers ; Korinna Joehrens ; Andre Zakarneh ; Bernadette Brzezicha ; Annika Wulf-Goldenberg ; Ulrich Keilholz ; Jens Hoffmann ; Iduna Fichtner	A comprehensively characterized large panel of head and neck cancer patient-derived xenografts identifies the mTOR inhibitor everolimus as potential new treatment option.
000D99 (2014)	L M Neri [Italie] ; A. Cani [Italie] ; A M Martelli [Italie] ; C. Simioni [Italie] ; C. Junghanss [Allemagne] ; G. Tabellini [Italie] ; F. Ricci [Italie] ; P L Tazzari [Italie] ; P. Pagliaro [Italie] ; J A Mccubrey [États-Unis] ; S. Capitani [Italie]	Targeting the PI3K/Akt/mTOR signaling pathway in B-precursor acute lymphoblastic leukemia and its therapeutic potential.
000E26 (2014)	Xinying Zhou [Pays-Bas] ; Yijin Wang [Pays-Bas] ; Herold J. Metselaar [Pays-Bas] ; Harry L A. Janssen [Canada] ; Maikel P. Peppelenbosch [Pays-Bas] ; Qiuwei Pan [Pays-Bas]	Rapamycin and everolimus facilitate hepatitis E virus replication: revealing a basal defense mechanism of PI3K-PKB-mTOR pathway.
000E33 (2014)	Mélodie Carbonnaux [France] ; Yann Molin ; Pierre-Jean Souquet ; Arnaud Tantin ; Catherine Lombard-Bohas ; Thomas Walter	Pneumocystis jirovecii pneumonia under everolimus in two patients with metastatic pancreatic neuroendocrine tumors.
000E92 (2014)	A. Wanitchanont [Thaïlande] ; P. Somparn [Thaïlande] ; S. Vadcharavivad [Thaïlande] ; W. Chancharoenthana [Thaïlande] ; N. Townamchai [Thaïlande] ; K. Praditpornsilpa [Thaïlande] ; Y. Avihingsanon [Thaïlande]	Effects of atorvastatin on the pharmacokinetics of everolimus among kidney transplant recipients.
000F27 (2014)	Carolina Simioni [Italie] ; Alice Cani [Italie] ; Alberto M. Martelli [Italie] ; Giorgio Zauli [Italie] ; Giovanna Tabellini [Italie] ; James Mccubrey [États-Unis] ; Silvano Capitani [Italie] ; Luca M. Neri [Italie]	Activity of the novel mTOR inhibitor Torin-2 in B-precursor acute lymphoblastic leukemia and its therapeutic potential to prevent Akt reactivation.
000F42 (2013)	Luciano Moscarelli [Italie] ; Leonardo Caroti ; Giulia Antognoli ; Maria Zanazzi ; Lorenzo Di Maria ; Paolo Carta ; Enrico Minetti	Everolimus leads to a lower risk of BKV viremia than mycophenolic acid in de novo renal transplantation patients: a single-center experience.
000F57 (2013)	F C Renner [Allemagne] ; H. Dietrich ; N. Bulut ; D. Celik ; E. Freitag ; N. Gaertner ; S. Karoui ; J. Mark ; C. Raatz ; R. Weimer ; A. Feustel	The risk of polyomavirus-associated graft nephropathy is increased by a combined suppression of CD8 and CD4 cell-dependent immune effects.
000F61 (2013)	Chie Nishioka [Japon] ; Takayuki Ikezoe ; Jing Yang ; Keiko Udaka ; Akihito Yokoyama	The combination of IκB kinase β inhibitor and everolimus modulates expression of interleukin-10 in human T-cell lymphotropic virus type-1-infected T cells.
000F99 (2013)	H-S Shiah [Taïwan] ; C-Y Chen ; C-Y Dai ; C-F Hsiao ; Y-J Lin ; W-C Su ; J-Y Chang ; J. Whang-Peng ; P-W Lin ; J-D Huang ; L-T Chen	Randomised clinical trial: comparison of two everolimus dosing schedules in patients with advanced hepatocellular carcinoma.
001053 (2013)	Eleonora Teplinsky [États-Unis] ; Derrick Cheung ; Ilan Weisberg ; Ramon E A. Jacobs ; Martin Wolff ; James Park ; Kent Friedman ; Franco Muggia ; Komal Jhaveri	Fatal hepatitis B reactivation due to everolimus in metastatic breast cancer: case report and review of literature.
001088 (2013)	Yoshinobu Saito [Japon] ; Mikie Nagayama ; Yukiko Miura ; Satoko Ogushi ; Yasutomo Suzuki ; Rintaro Noro ; Yuji Minegishi ; Go Kimura ; Yukihiro Kondo ; Akihiko Gemma	A case of pneumocystis pneumonia associated with everolimus therapy for renal cell carcinoma.
001117 (2012)	Teruhiko Imamura [Japon] ; Taro Shiga ; Koichiro Kinugawa ; Naoko Kato ; Miyoko Endo ; Toshiro Inaba ; Hisataka Maki ; Masaru Hatano ; Atsushi Yao ; Yasunobu Hirata ; Ryozo Nagai	Successful conversion to everolimus after cytomegalovirus infection in a heart transplant recipient.
001140 (2012)	Audrey Coilly [France] ; Valérie Furlan ; Bruno Roche ; Caroline Barau ; Coralie Noël ; Laurence Bonhomme-Faivre ; Teresa Maria Antonini ; Anne-Marie Roque-Afonso ; Didier Samuel ; Anne-Marie Taburet ; Jean-Charles Duclos-Vallée	Practical management of boceprevir and immunosuppressive therapy in liver transplant recipients with hepatitis C virus recurrence.
001178 (2012)	Aaron James Chan [États-Unis] ; John R. Lake	Immunosuppression in HCV-positive liver-transplant recipients.
001231 (2012)	Ruth Bauer [Allemagne] ; Markus Mezger ; Christian Blockhaus ; Anna-Lena Schmitt ; Oliver Kurzai ; Hermann Einsele ; Juergen Loeffler	40-O -[2-Hydroxyethyl]rapamycin modulates human dendritic cell function during exposure to Aspergillus fumigatus.
001233 (2011)	T. Casanovas [Espagne] ; A. Argudo ; M C Pe A-Cala	Effectiveness and safety of everolimus in the treatment of autoimmune hepatitis related to anti-hepatitis C virus therapy after liver transplant: three case reports.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Bois/explor/RapamycinFungusV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdFr.i -k "Évérolimus (MeSH)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdFr.i  \
                -Sk "Évérolimus (MeSH)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Bois
   |area=    RapamycinFungusV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdFr.i
   |clé=    Évérolimus (MeSH)
}}

---

This area was generated with Dilib version V0.6.38. Data generation: Thu Nov 19 21:55:41 2020. Site generation: Thu Nov 19 22:00:39 2020